Rescue of a H3N2 influenza virus containing a deficient neuraminidase protein by a hemagglutinin with a low receptor-binding affinity

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Richard, Mathilde ^a,c   Erny, Alexandra ^a,c   Caré, Bertrand ^b,c   Traversier, Aurélien ^a,c   Barthélémy, Mendy ^a,c   Hay, Alan ^b,c   Lin, Yi Pu ^b,c   Ferraris, Olivier ^a,c   Lina, Bruno ^a,c  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ DE LYON   (France)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; RECEPTOR; SIALIC ACID ALPHA2.3 GALACTOSE RECEPTOR; SIALIC ACID ALPHA2.6 GALACTOSE RECEPTOR; UNCLASSIFIED DRUG; VIRUS SIALIDASE; CELL SURFACE RECEPTOR; HN PROTEIN RECEPTOR; SIALIC ACID RECEPTOR; SIALIDASE; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING KINETICS; ENZYME ACTIVITY; INFLUENZA VIRUS A H3N2; NONHUMAN; RECEPTOR BINDING; VIROGENESIS; ANIMAL; BINDING COMPETITION; CELL LINE; FLOW CYTOMETRY; GENETIC COMPLEMENTATION; GENETIC TRANSFECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; KINETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; PROTEIN BINDING;

ORTHOMYXOVIRIDAE;

ANIMALS; BINDING, COMPETITIVE; CELL LINE; FLOW CYTOMETRY; GENETIC COMPLEMENTATION TEST; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; KINETICS; MOLECULAR SEQUENCE DATA; MUTATION; NEURAMINIDASE; PROTEIN BINDING; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; TRANSFECTION;

EID: 84860466711     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033880     Document Type: Article

References (24)

1. Gubareva LV, Bethell R, Hart GJ, Murti KG, Penn CR, et al. (1996) Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. J Virol 70: 1818-1827.
2. McKimm-Breschkin JL, Sahasrabudhe A, Blick TJ, McDonald M, Colman PM, et al. (1998) Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J Virol 72: 2456-2462.
3. Mochalova L, Bright R, Xu X, Korchagina E, Chinarev A, et al. (2010) Shift in oligosaccharide specificities of hemagglutinin and neuraminidase of influenza B viruses resistant to neuraminidase inhibitors. Glycoconj J 27: 321-327.
4. Baz M, Abed Y, Boivin G, (2007) Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir. Antiviral Res 74: 159-162.
5. Hughes MT, Matrosovich M, Rodgers ME, McGregor M, Kawaoka Y, (2000) Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice. J Virol 74: 5206-5212.
6. Yang P, Bansal A, Liu C, Air GM, (1997) Hemagglutinin specificity and neuraminidase coding capacity of neuraminidase-deficient influenza viruses. Virology 229: 155-165.
7. Baigent SJ, McCauley JW, (2001) Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture. Virus Res 79: 177-185.
8. Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, et al. (2000) Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol 74: 6015-6020.
9. Lu B, Zhou H, Ye D, Kemble G, Jin H, (2005) Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics. J Virol 79: 6763-6771.
10. Kobasa D, Kodihalli S, Luo M, Castrucci MR, Donatelli I, et al. (1999) Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase. J Virol 73: 6743-6751.
11. Kaverin NV, Gambaryan AS, Bovin NV, Rudneva IA, Shilov AA, et al. (1998) Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match. Virology 244: 315-321.
12. Kaverin NV, Matrosovich MN, Gambaryan AS, Rudneva IA, Shilov AA, et al. (2000) Intergenic HA-NA interactions in influenza A virus: postreassortment substitutions of charged amino acid in the hemagglutinin of different subtypes. Virus Res 66: 123-129.
13. Ilyushina NA, Rudneva IA, Shilov AA, Klenk HD, Kaverin NV, (2005) Postreassortment changes in a model system: HA-NA adjustment in an H3N2 avian-human reassortant influenza virus. Arch Virol 150: 1327-1338.
14. Ferraris O, Kessler N, Valette M, Lina B, (2006) Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005. Vaccine 24: 6656-6659.
15. Moules V, Ferraris O, Terrier O, Giudice E, Yver M, et al. (2010) In vitro characterization of naturally occurring influenza H3NA- viruses lacking the NA gene segment: toward a new mechanism of viral resistance? Virology 404: 215-224.
16. Richard M, Ferraris O, Erny A, Barthelemy M, Traversier A, et al. (2011) Combinatorial effect of two E119V+I222L framework mutations in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivir. Antimicrob Agents Chemother.
17. Gubareva LV, Robinson MJ, Bethell RC, Webster RG, (1997) Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en. J Virol 71: 3385-3390.
18. Boltz DA, Douangngeun B, Phommachanh P, Sinthasak S, Mondry R, et al. (2010) Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic. J Gen Virol 91: 949-959.
19. Sauter NK, Glick GD, Crowther RL, Park SJ, Eisen MB, et al. (1992) Crystallographic detection of a second ligand binding site in influenza virus hemagglutinin. Proc Natl Acad Sci U S A 89: 324-328.
20. Ohuchi M, Feldmann A, Ohuchi R, Klenk HD, (1995) Neuraminidase is essential for fowl plague virus hemagglutinin to show hemagglutinating activity. Virology 212: 77-83.
21. Luo C, Nobusawa E, Nakajima K, (1999) An analysis of the role of neuraminidase in the receptor-binding activity of influenza B virus: the inhibitory effect of Zanamivir on haemadsorption. J Gen Virol 80 (Pt 11): 2969-2976.
22. Linderman JJ, Lauffenburger DA, (1993) Receptors: models for binding, trafficking, and signalling. Oxford University Press.
23. Akaike H, (1978) A Bayesian Analysis of the Minimum AIC Procedure. Ann Inst Statist Math 30: 9-14.
24. Reed LJ, Muench H, (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27: 493-497.